Trends in prostate-specific antigen test use, 2000-2005
- PMID: 21387953
- PMCID: PMC3056036
- DOI: 10.1177/003335491112600214
Trends in prostate-specific antigen test use, 2000-2005
Abstract
Objective: This study examined prostate-specific antigen (PSA) test use among men and identified sociodemographic and health-related characteristics associated with its use over time.
Methods: The National Health Interview Survey collected information on PSA test use among 16,058 men > or = 40 years of age in 2000 and 2005. We examined two outcomes: (1) having had a recent (within two years) screening PSA test and (2) having had three or more PSA tests in the past five years (to indicate frequent use).
Results: Marital status, family history of prostate cancer, and having seen a doctor in the past year differed over time in the unadjusted model. In the adjusted model, recent PSA screening decreased from 2000 to 2005 for single, never-married men, but increased for men with chronic diseases. Frequent PSA test use increased for men with a family history of prostate cancer, men with chronic diseases, and men who had seen a physician in the past year. Significant correlates of higher recent PSA test use included being older, married, and of black race/ethnicity; having higher levels of education and income, health-care coverage, and a usual place of health care; and increased comorbidity.
Conclusion: Major organizations are not in agreement about the efficacy of prostate cancer screening; however, men > or = 40 years of age continue to use the PSA test. Both recent screening and frequent testing showed variability during the study period and may have implications for the ongoing randomized clinical trials that are expected to clarify whether early detection of prostate cancer with PSA testing increases survival.
Similar articles
-
Patterns in prostate-specific antigen test use and digital rectal examinations in the Behavioral Risk Factor Surveillance System, 2002-2006.J Natl Med Assoc. 2009 Apr;101(4):316-24. doi: 10.1016/s0027-9684(15)30878-6. J Natl Med Assoc. 2009. PMID: 19397221
-
Use of the prostate-specific antigen test among U.S. men: findings from the 2005 National Health Interview Survey.Cancer Epidemiol Biomarkers Prev. 2008 Mar;17(3):636-44. doi: 10.1158/1055-9965.EPI-07-2709. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18349281
-
A population-based survey of prostate-specific antigen testing among California men at higher risk for prostate carcinoma.Cancer. 2006 Feb 15;106(4):765-74. doi: 10.1002/cncr.21673. Cancer. 2006. PMID: 16419068
-
Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence.JAMA. 2014 Mar 19;311(11):1143-9. doi: 10.1001/jama.2014.2085. JAMA. 2014. PMID: 24643604 Review.
-
Population screening for prostate cancer and emerging concepts for young men.Clin Prostate Cancer. 2003 Sep;2(2):87-97. doi: 10.3816/cgc.2003.n.015. Clin Prostate Cancer. 2003. PMID: 15040869 Review.
Cited by
-
Prostate-specific antigen (PSA) screening rates and factors associated with screening in Eastern Canadian men: Findings from cross-sectional survey data.Can Urol Assoc J. 2020 Jul;14(7):E319-E327. doi: 10.5489/cuaj.6072. Can Urol Assoc J. 2020. PMID: 32017690 Free PMC article.
-
Emerging cancer incidence, mortality, hospitalisation and associated burden among Australian cancer patients, 1982 - 2014: an incidence-based approach in terms of trends, determinants and inequality.BMJ Open. 2019 Dec 15;9(12):e031874. doi: 10.1136/bmjopen-2019-031874. BMJ Open. 2019. PMID: 31843834 Free PMC article.
-
Association Between Antidiabetic Medications and Prostate-Specific Antigen Levels and Biopsy Results.JAMA Netw Open. 2019 Nov 1;2(11):e1914689. doi: 10.1001/jamanetworkopen.2019.14689. JAMA Netw Open. 2019. PMID: 31693126 Free PMC article.
-
Prostate Cancer Mortality-To-Incidence Ratios Are Associated with Cancer Care Disparities in 35 Countries.Sci Rep. 2017 Jan 4;7:40003. doi: 10.1038/srep40003. Sci Rep. 2017. PMID: 28051150 Free PMC article.
-
Determinants of Prostate Cancer Screening Intentions of Young Black Men Aged 18 to 40 Years.J Racial Ethn Health Disparities. 2016 Nov 18. doi: 10.1007/s40615-016-0305-1. Online ahead of print. J Racial Ethn Health Disparities. 2016. PMID: 27864809
References
-
- U.S. Cancer Statistics Working Group. United States cancer statistics: 2002 incidence and mortality. Atlanta: Department of Health and Human Services (US), Centers for Disease Control and Prevention, and National Cancer Institute; 2005.
-
- American Cancer Society. Cancer facts and figures 2009. Atlanta: American Cancer Society; 2009.
-
- Bellizzi KM, Latini DM, Cowan JE, Duchane J, Carroll PR. Fear of recurrence, symptom burden, and health-related quality of life in men with prostate cancer. Urology. 2008;72:1269–73. - PubMed
-
- Amling CL. Prostate-specific antigen and detection of prostate cancer: what have we learned and what should we recommend for screening? Curr Treat Options Oncol. 2006;7:337–45. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
